|
OTLC | Oncotelic Therapeutics, Inc. |
|
|
OTLC | Oncotelic Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 39.36 |
| Leverage | 33.42% |
| Market Cap | $ 20.0m |
| PE | 0.08 |
| Dividend Yield | 0.00% |
| Profit | $ 244.7m |
| Margin | 68.02% |